Stocks climbed in early trading on Wall Street Thursday as reports suggested that even though the economy is still suffering severely, the pace of pain may be decelerating. The S&P 500 rose 1.3%, following similar gains in Europe. The day’s headliner economic report showed another 3.2 million U.S. workers applied for jobless benefits last week, bringing the total over the last seven weeks to 33.5 million. It’s a shocking number, but it’s also the fifth straight week of decline since hitting a peak in late March. Several companies including Lyft and PayPal said they were seeing some encouraging trends in their businesses.

THIS IS A BREAKING NEWS UPDATE. AP’s earlier story is below:

Stock markets and the price of oil pushed higher on Thursday ahead of the latest weekly jobless claims figures in the U.S. and after China reported a rise in exports as its pandemic lockdown eased.

As more countries start to remove the draconian limits on business and public life, investors are trying to gauge how quickly the global economy might bounce back.

The labor market in the United States has been a focal point. On Thursday, government data will likely show that about 3.5 million people sought jobless aid last week, bringing the total to nearly 34 million since the shutdowns began seven weeks ago. On Friday, a monthly report is expected to show that the unemployment rate jumped to at least 16% in April — from just 4.4% in March.

Wall Street futures were up ahead of the start to trading, with Dow futures up 1.3% and those for the S&P 500 up 1.4%.

In Europe, France’s CAC 40 gained 0.8% to 4,470. Germany’s DAX also added 0.8%, to 10,692, while Britain’s FTSE 100 rose 0.7% to 5,895.

The Chinese trade data showed an encouraging 3.5% rise in exports in April, driven by electronics shipments and textiles, which included a surge in mask exports.

The data show China’s exports to the United States rose 2.2% in April, while imports of American goods fell 11% in a reflection of weak Chinese industrial and consumer demand despite the lifting of most anti-virus controls.

Imports fell 13.7% from a year earlier to $179.6 billion, worse than the first quarter’s 2.9% decline. But total exports rose to $200.3 billion, a turnaround from the 13.3% contraction in the three months ending in March.

Forecasters warned that strength is unlikely to last as the coronavirus pandemic depresses global consumer demand.

Comments by President Donald Trump raising the possibility of further trade friction with Beijing have worried investors hoping for better times as other economies begin to reopen from pandemic shutdowns.

Trump said he would soon assess progress in a preliminary trade agreement with China that took effect in January, extending a truce in a painful tariffs war between the world’s two biggest economies.

The possibility of revived friction over trade at a time when economies have been slammed by the pandemic and resulting travel restrictions has rattled investors in Asia, where China is the main driver for regional growth.

“President Trump’s latest threat to impose additional tariffs on China could also bring some front-loading exports in the near term," Wang said.

Most Asian markets slipped Thursday, but Japan's benchmark Nikkei 225, reopening after Golden Week holidays, gained 0.3% to finish at 19,674.77.

South Korea's Kospi was little changed, inching down less than 0.1% to 1,928.61. Australia's S&P/ASX 200 lost 0.4% to 5,364.20. Hong Kong's Hang Seng fell 0.7% to 23,980.63, while the Shanghai Composite fell 0.2% to 2,871.52.

Benchmark U.S. crude surged $2.51 to $26.50a barrel in electronic trading on the New York Mercantile Exchange. It fell 57 cents, or 2.3%, to $23.99 a barrel Wednesday.

Brent crude oil, the international standard, gained $1.98 to $31.70 a barrel.

The dollar inched up to 106.60 Japanese yen from 106.13 yen Wednesday. The euro weakened to $1.0790 from $1.0795.

___

AP Business Writer Joe McDonald contributed.

Share:
More In Business
TC BioPharm Goes Public, Looks to Future of Cancer, COVID-19 Cell Therapies
TC BioPharm, a biopharmaceutical company focused on developing cell therapy products targeting, went public on the Nasdaq in January. CEO Bryan Kobel joined Cheddar to talk about the company's IPO launch, its cancer-fighting therapeutics tech, and its potential for using its research to treat COVID-19. "The opportunity here for us is to really get safety data and covid and expand into other areas," Kobel said. "So from COVID, where we hope to treat patients, hopefully maybe the elderly population, populations that that really can't handle the antivirals because they're too hard in the system, well then we'll expand out into maybe severe influenza Ebola, other viral and viral infections where we think we can be helpful."
A Closer Look at the Gaming Sector and its Future in the Metaverse
The gaming industry has been under the spotlight so far this year following some big mergers and acquisitions. This week featured earnings of three major gaming companies, but also Meta and for the latter, things are not doing too hot. Joining Cheddar News to break it all down was Kenny Rosenblatt, President and Co-Founder of Arkadium.
Economy Appears to Be Back on Track in 2022 With Job Growth
Following the surprising big beat on estimates for the January jobs report, William M. Rodgers III, vice president and director of the Institute for Economic Equity at the Federal Reserve Bank of St. Louis, joined Cheddar News to break down the data. “We ended 2021 with a strong crescendo to a recovery that had taken hold, and we started 2022 in good fashion." He also discussed the dueling pressures of wage growth and inflation.
Amazon Strong Growth Attributed to the Cloud Despite Retail Headwinds
While it was a volatile week in tech as Meta experienced the biggest one-day drop in the history of the U.S. stock market, industry giant Amazon reported 40 percent growth — largely on the strength of the cloud. Dan Ives, managing director of equity research at Wedbush Securities, joined Cheddar News to break down how the e-commerce company stock managed to pop despite headwinds against its core retail business. "It's all about cloud because of sum of the parts, you could argue, amazon could be $3,500/$4,000 stock just based on cloud," he said. Ives also addressed the apparent the differing impact of Apple iOS changes on Facebook and Snapchat.
Investors May Be Wary of Ford Due to Ongoing Supply Chain Issues
Following Ford's earnings miss, the stock price dropped despite a bullish outlook from the auto giant. Karl Brauer, an executive analyst with ISeeCars.com, joined Cheddar to break down why investors may not be sold on the carmaker because of the ongoing factor of supply constraints. "The product is not an issue. There's really good product coming from them, including the electric vehicle side, and the demand is not an issue. There's plenty of demand, but nobody really has a solid grasp on when we're going to get past the supply chain issue," said Brauer.
Load More